Health News

Although some reports have suggested a link between the use of oral bisphosphonates (drugs that prevent the loss of bone mass) and esophageal cancer, analysis of medical data from more than 80,000 patients in the United Kingdom found that use of these drugs was not significantly associated with new cases of esophageal or gastric cancer, according to a study in the August 11 issue of JAMA…

Read more

Filed under: Women's Health
Tags: cancer, Drug, Women's Health

Related posts

• Women’s Health Policy Report Highlights Studies From Recent Breast Cancer Conference (0)
  The following summarizes findings reported last week at the San Antonio Breast Cancer Symposium. ~ Anthracyclines: New research suggests that anthracyclines -- a class of chemotherapy drugs commonly used to treat breast cancer -- could cause more harm than benefits for breast cancer patients because they can be damaging to the heart, the Wall Street [...]
  
  
• Vitamin D Relieves Joint, Muscle Pain For Breast Cancer Patients (0)
  High-dose vitamin D relieves joint and muscle pain for many breast cancer patients taking estrogen-lowering drugs, according to a new study from Washington University School of Medicine in St. Louis. The drugs, known as aromatase inhibitors, are commonly prescribed to shrink breast tumors fueled by the hormone estrogen and help prevent cancer recurrence... Read more [tags] Women's [...]
  
  
• The Future Of Breast Cancer Prevention (0)
  Drugs could be used to prevent breast cancer in women at high risk of the disease in the same way that statins are used for heart disease if trials looking at ways of predicting risk are successful, according to an international panel of cancer experts... Read more [tags] Women's Health [/tags]
  
  
• Test Selects The 60 Per Cent Of Women With Inherited Ovarian Cancer Who Could Benefit From ‘Smart’ Drug (0)
  Scientists have developed a new test to select which patients with ovarian cancer will benefit from new drugs called PARP inhibitors, according to research presented at the NCRI Cancer Conference in Liverpool today. PARP inhibitors are the first targeted treatment to be developed for women with inherited forms of breast and ovarian cancer carrying faults [...]
  
  
• Study Offers Hope For Women With ER-Negative Breast Cancer (0)
  Women who have estrogen (ER)-negative breast cancer may have more drug-treatment options than previously thought, a Creighton (pronounced Cray-ton) University study suggests. The study is reported in the Oct. 11 online version of the journal Oncogene... Read more [tags] Women's Health [/tags]